Expert Voices

One question. Different countries.

The same clinical question, seen through different health systems. This is about perspectives across borders — not a ranking of experts.

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

What will change diabetes care most over the next five years?

Type 2 Diabetes · updated 2026-01

🇮🇳

India

Endocrinology

"Affordability and early, phenotype-aware treatment will matter most — scaling access to proven agents beyond metros is the key challenge."

Dr. A. Rao (illustrative) · Representative tertiary endocrinology centre, India

🇸🇬

Singapore

Diabetology

"Digital-first, structured chronic-disease programmes and earlier population screening will shape outcomes more than any single drug."

Dr. L. Tan (illustrative) · Representative diabetes service, Singapore

🇬🇧

United Kingdom

Diabetes & Endocrinology

"Cost-effectiveness and remission-focused pathways will guide which newer therapies are routinely offered."

Dr. R. Clarke (illustrative) · Representative NHS diabetes centre, UK

🇺🇸

United States

Endocrinology

"Incretin-based therapies and continuous glucose monitoring will keep reframing care around weight and cardiometabolic risk."

Dr. M. Bennett (illustrative) · Representative academic medical centre, USA

🇦🇺

Australia

Diabetes

"Primary-care-led models and PBS-subsidised access will determine how quickly innovations reach everyday practice."

Dr. S. Nguyen (illustrative) · Representative diabetes service, Australia

Expert profiles

🇮🇳

Dr. A. Rao (illustrative)

Endocrinology · India

Representative tertiary endocrinology centre, India

Expertise

Type 2 diabetes, early-onset diabetes, affordability of care

Metabolic Health

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

🇸🇬

Dr. L. Tan (illustrative)

Diabetology · Singapore

Representative diabetes service, Singapore

Expertise

Structured chronic disease programmes, digital health

Metabolic Health

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

🇬🇧

Dr. R. Clarke (illustrative)

Diabetes & Endocrinology · United Kingdom

Representative NHS diabetes centre, UK

Expertise

Guideline-based care, structured education

Metabolic Health

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

🇺🇸

Dr. M. Bennett (illustrative)

Endocrinology · United States

Representative academic medical centre, USA

Expertise

Incretin therapies, CGM, obesity medicine

Metabolic Health

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

🇦🇺

Dr. S. Nguyen (illustrative)

Diabetes · Australia

Representative diabetes service, Australia

Expertise

Primary-care-led diabetes care, PBS access

Metabolic Health

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.

🇬🇧

Dr. H. Osei (illustrative)

Cardiology · United Kingdom

Representative cardiology centre, UK

Expertise

Hypertension pathways, out-of-office monitoring

Cardiovascular

Illustrative, representative profile for educational purposes. Not a real individual; no real quotes or credentials are implied.